# Corporate Genealogy — Neurotech Packet Synthesis **Date:** 2026-09-11 **Packet source:** [[research/Research Packets - Shard 01 - 2026-09-11|Research Packets — Shard 01 Completion Ledger]] ## Forest Neurotech to Arbor Neuroscience [[wiki/Forest Neurotech|Forest Neurotech]] was founded in 2023 as a nonprofit Focused Research Organization within Convergent Research. [[wiki/Arbor Neuroscience|Arbor Neuroscience]] is its confirmed 2026 name and programmatic continuation. The organization retains Forest 1 as its starting platform while changing leadership and focusing the mission on predictable, model-guided neuromodulation. This is a `VERIFIED` rename and continuation. ## Forest and Merge Labs [[wiki/Merge Labs|Merge Labs]] shares Forest founders Sumner Norman and Tyson Aflalo and includes Forest advisor Mikhail Shapiro as a co-founder. OpenAI is an investor and research collaborator in Merge. The supported genealogy is personnel and technical lineage from the Forest ultrasound program into Merge’s biology-device-AI interface program. The packet does not establish acquisition, corporate succession, or transfer of the Forest/Arbor organization; those remain settlement questions for corporate and patent records. ## Cortical Labs, NUS Medicine, and DayOne [[wiki/Cortical Labs|Cortical Labs]] developed DishBrain, CL1, biOS, and Cortical Cloud. [[wiki/NUS Medicine|NUS Medicine]] and [[wiki/DayOne|DayOne]] enter through a formal prototype partnership: NUS grows and supervises the cells, DayOne supplies datacentre infrastructure, and Cortical Labs supplies biological-computing units and software. The relationship is a deployment and development partnership with distinct institutional roles. ## FinalSpark and Neuroplatform [[wiki/FinalSpark|FinalSpark]] operates [[wiki/Neuroplatform|Neuroplatform]]. Here the platform is a service layer within the same company genealogy: biological culture, instrumentation, remote access, and data operations are offered as one managed system. The model contrasts with Cortical Labs’ appliance-and-rack path while converging on the same reliability and tissue-lifetime gates. ## Zetta AI and academic connectomics [[wiki/Zetta AI|Zetta AI]] commercializes reconstruction services through a team and publication lineage overlapping FlyWire and MICrONS. This is `STRONG_TECHNICAL_LINEAGE` based on shared authorship and pipeline contribution. The ownership, grant, and contract structure connecting the company to Princeton or BRAIN CONNECTS remains `UNRESOLVED` until corporate filings and award instruments are available. ## Capital as lineage signal Capital marks different coupling strengths in this tranche: - OpenAI’s participation in Merge combines investment with an announced research collaboration. - Paradromics’ venture rounds and NIH/DARPA grants combine private scale-up with public technical ancestry. - ARIA funds a clinical research program using Forest 1, binding a U.K. public research instrument to the Forest/Arbor technical line. - Philanthropic support and the FRO structure bind Forest/Arbor and E11 Bio to open-tool missions rather than conventional venture exits. Each instrument is recorded by type. Shared investors, advisers, or founders are genealogy signals whose organizational meaning depends on the contract, filing, or governance record that binds them. ## Primary sources - [Arbor Neuroscience — organizational continuity](https://www.arborneuroscience.org/about.html) - [OpenAI — investment and research collaboration with Merge Labs](https://openai.com/index/investing-in-merge-labs/) - [NUS Medicine — three-party biological datacentre partnership](https://medicine.nus.edu.sg/news/nus-medicine-dayone-and-cortical-labs-unveil-biological-data-center-prototype-in-singapore/) - [FinalSpark — Neuroplatform](https://finalspark.com/neuroplatform/) - [Zetta AI — reconstruction services and publications](https://zetta.ai/)